Clinical Study
High 15-F2t-Isoprostane Levels in Patients with a Previous History of Nonmelanoma Skin Cancer: The Effects of Supplementary Antioxidant Therapy
Table 3
Comparison regarding sociodemographic characteristics from placebo and supplemented groups before supplementation.
| | Placebo () | Supplemented () | value |
| Sociodemographic characteristics | | | | Age (years) (mean ± SD) | 65.6 ± 13.2 | 59.0 ± 14.9 | 0.0860a | Sex (female), (%) | 24 (70.6) | 15 (57.7) | 0.2994b | Smoking, (%) | 4 (11.8) | 4 (15.4) | 0.7172c | Alcoholism, (%) | 2 (5.9) | 7 (26.9) | 0.0323c | Use of sunscreen, (% ) | 22 (64.7) | 19 (73.1) | 0.4987b | Mean daily sunlight exposure (mean ± SD) | 199.4 ± 130.2 | 155.8 ± 112.5 | 0.2450a | Family history of cancer, (%) | 24 (70.6) | 18 (69.2) | 0.9095b | Race, (%) | | | 0.5072c | Caucasian | 5 (14.7) | 6 (23.1) | | Non-Caucasian | 29 (85.3) | 20 (76.9) | | Anthropometric parameters (mean ± SD) | | | | BMI (kg/m2) | 27.0 ± 4.1 | 25.8 ± 3.2 | 0.3440a | TSF (mm) | 18.1 ± 7.4 | 17.5 ± 8.3 | 0.9100a | MUAC (cm) | 30.0 ± 4.7 | 30.2 ± 4.2 | 0.6710a | MAMC (cm) | 24.8 ± 4.0 | 24.1 ± 4.1 | 0.7670a | Daily intake levels (mean ± SD) | | | | Vitamin A (g) | 705.3 ± 778.6 | 428.2 ± 232.4 | 0.8817a | Vitamin C (mg) | 55.7 ± 47.6 | 54.2 ± 46.5 | 0.7326a | Vitamin E (mg) | 9.0 ± 4.0 | 9.9 ± 9.3 | 0.6157a | Cuprum (g) | 950.0 ± 510.0 | 870.0 ± 280.0 | 0.0784a | Zinc (g) | 7.1 ± 4.4 | 5.8 ± 2.4 | 0.1321a | Selenium (g) | 79.8 ± 47.4 | 76.9 ± 21.5 | 0.1979a |
|
|
= total of subjects/patients, SD = standard deviation, BMI = body mass index, TSF = triceps skinfold, MUAC = mid-upper-arm circumference, and MAMC = mid-arm muscle circumference. Statistical analysis: aMann-Whitney test; bChi-square test; cFisher’s exact test.
|